Check out your Company Bowl for anonymous work chats.
Ep.6 Morgan James: The Renaissance of Manufacturing in Australia & The Iron Triangle of Healthcare
BBFH22 Final Event - Powerhouse Museum
BBFH Series - Sam van Bohemen: Winning the BBFH Challenge
BBFH Series - Sam van Bohemen: Next Development Stage Thanks to Winning BBFH
Our host, Richard Sokolov, Executive Director and Co-founder of IDE Group, speaks with Sam van Bohemen, Co-founder and CEO of Nuroflux. Richard and Sam discuss how Nuroflux is trying to solve the $6 Billion problem with a novel approach, why technology isn’t everything, and what you need as a founder for a successful commercial outcome. About Sam van Bohemen and Nuroflux There is a stroke every 19 minutes in Australia, and the associated costs are $6 billion annually just for Australians. Stroke is the second leading cause of death worldwide. Unfortunately, current standard care relies upon subjective observations, and CT perfusion scans do not provide continuous monitoring. However, for an oxygen-starved brain, every second counts. That is why Sam, founder and CEO of Nuroflux, wants to revolutionise stroke patient care with the first-ever device for continuous, long-term monitoring of brain activity and blood flow in the brain. Their solution is a wearable device for real-time monitoring of patients with acute ischaemic stroke.
Ep.4 Interview with Dr Alan Taylor: How to Raise Capital and the Mission to Improve Cancer Treatment
Ep.3 Anne O'Neill and Her Mission to Add Value to the Medical Research Community in New South Wales
Ep.2 Professor Watson on Ocurep's Mission to Reinvent Eye Surgery and Eliminate Corneal Blindness
Ep.1 Mick Brooks, Head of R&D at Bayer on Australia's Culture of Innovation
The Internet of Medical Things (IoMT) offers exciting possibilities to improve patient care. Organisations increasingly realise the transformative nature of connected healthcare devices, and adoption is accelerating. We recently spoke to our Software Engineer and Solutions Architect, George Petrakis, about IoMT, connected healthcare devices and their risk factors. We also spoke about some of IDE’s projects in that area and the challenges the sector is facing.
